September 02, 2025

New Bruton’s Tyrosine Kinase Inhibitor Improves Platelet Response

The FDA has approved rilzabrutinib (Wayrilz) as the first Bruton’s tyrosine kinase inhibitor for adults with chronic or persistent immune thrombocytopenia who have had an insufficient response to prior therapy.

Conexiant

September 01, 2025

Dental School Is Worth the Investment

One student’s reflections on her personal journey

Inside Dentistry

September 01, 2025

From Stage Play to Gameplay

From Stage Play to Gameplay

Inside Dentistry

August 29, 2025

Gastrointestinal Foreign Bodies: When to Use Computed Tomography Versus Radiograph

A physician-focused review of gastrointestinal foreign body ingestion is looking to guide triage and intervention.

Conexiant

August 28, 2025

First Generic GLP-1 for Weight Loss Approved

FDA approves Teva’s generic Saxenda (liraglutide) with adult and adolescent indications and a boxed thyroid tumor warning.

Conexiant

August 28, 2025

Girl With Waterdrop-Like Papules: What’s Your Diagnosis?

A teenager with atopic dermatitis presented with several painless, flesh-colored papules limited to the trunk. Dermoscopy and biopsy show selective loss of elastic fibers after prior molluscum contagiosum. What’s your diagnosis?

Conexiant

August 27, 2025

FDA Approves LP.8.1 COVID-19 Vaccines

LP.8.1-targeted COVID-19 vaccines for adults 65 and older and higher-risk patients were approved by the US Food and Drug Administration.

Conexiant

August 27, 2025

Educational, Digital, Campaign Tools Cut Antibiotic Use

Antibiotic prescribing for common respiratory tract infections was more frequent in urgent care than in primary care, with patterns shaped by patient age and diagnosis.

Conexiant

August 27, 2025

Remission Patterns in Youth at Risk for Psychosis

When participants had at least 1 follow-up visit after achieving remission, the likelihood of staying in remission increased. 

Conexiant